Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection-Reference-Cited by-同舟云学术

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection

Published:2020-07-03 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

van der Zwan Marieke,Clahsen-Van Groningen Marian C.,van den Hoogen Martijn W. F.,Kho Marcia M. L.,Roodnat Joke I.,Mauff Katya A. L.,Roelen Dave L.,van Agteren Madelon,Baan Carla C.,Hesselink Dennis A.

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference29 articles.

1. Treatment of steroid-resistant acute renal allograft rejection with alemtuzumab;van den Hoogen;Am J Transplant.,2013

2. Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients;Csapo;Transplant Proc.,2005

3. Reversal of acute cellular rejection after renal transplantation with Campath-1H;Basu;Transplant Proc.,2005

4. Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up;Clatworthy;Transplantation.,2009

5. Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection;Rebello;Transplantation.,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressants against acute kidney injury: what to prefer or to avoid?;Immunopharmacology and Immunotoxicology;2024-03-18

2. Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection;World Journal of Transplantation;2023-12-18

3. A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection;Transplant International;2023-11-07

4. The detrimental effect of donor-specific antibodies is irrespective of its level in highly-immunized living donor kidney transplant recipients: A case-control series;Frontiers in Immunology;2023-01-10

5. Investigational drugs for the treatment of kidney transplant rejection;Expert Opinion on Investigational Drugs;2022-10-03